首頁 > 市場調查報告書 > 製藥

循環系統

動脈瘤性蜘蛛網膜下腔出血市場規模、佔有率和成長分析：按治療方法、最終用戶、分銷管道和地區分類－2026-2033年產業預測

市場調查報告書

商品編碼

2091162

動脈瘤性蜘蛛網膜下腔出血市場規模、佔有率和成長分析：按治療方法、最終用戶、分銷管道和地區分類－2026-2033年產業預測

Aneurysmal Subarachnoid Hemorrhage Market Size, Share, and Growth Analysis, By Intervention Type, By End-User, By Distribution Channel, By Region - Industry Forecast 2026-2033

出版日期: 2026年07月07日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2024 年全球動脈瘤性蜘蛛網膜下腔出血市場價值為 1.7 億美元，預計到 2033 年將從 2025 年的 1.734 億美元成長至 2.0317 億美元，預測期（2026-2033 年）的複合年成長率為 2.0%。

全球動脈瘤性蜘蛛網膜下腔出血 (aSAH) 市場涵蓋診斷工具、血管內治療器械、神經外科手術器械以及旨在治療顱內動脈瘤破裂的患者照護服務。鑑於其高死亡率和在所有卒中病例中所佔的顯著比例，迫切需要採用先進的影像技術和微創治療方法。該市場已從外科夾閉術轉向血管內治療，這主要得益於彈簧圈栓塞術的普及。這種轉變強調快速乾預，促使對CT和MRI等尖端影像技術的投資增加。這些技術不僅提高了診斷準確性，也擴大了患者的治療機會。人工智慧驅動的診斷影像技術的整合透過提高檢測準確性和加快臨床決策速度，進一步加速了這一趨勢，最終帶來更大的市場機會，尤其是在新興地區。

全球動脈瘤性蜘蛛網膜下腔出血市場成長要素

全球動脈瘤性蜘蛛網膜下腔出血市場的主要促進因素之一是腦動脈瘤發生率的上升以及高血壓、吸菸和遺傳易感性等相關風險因素的增加。隨著人們對神經系統疾病的認知不斷提高，對先進診斷和治療方法的需求也隨之成長。人口老化加劇了這一趨勢，因為老年族群的腦血管疾病發生率通常較高。微創手術技術的創新和專用醫療設備的研發也在推動市場成長，因為醫療專業人員正在尋求有效的治療方法，以改善患者預後並減輕這一重大健康問題的負擔。

全球動脈瘤性蜘蛛網膜下腔出血市場的限制因素

全球動脈瘤性蜘蛛網膜下腔出血市場的主要限制因素之一是先進影像技術和治療的高昂費用。這些費用會限制病患和醫療服務提供者獲得治療的機會，尤其是在資源匱乏的地區。此外，疾病的複雜性通常需要多學科診療，這給醫療預算帶來了額外的負擔。另外，大眾對動脈瘤性蜘蛛網膜下腔出血的認知和了解不足會導致診斷延遲，阻礙及時治療，並對整體市場成長產生負面影響。因此，這些因素會阻礙對這一關鍵醫療領域的投資和創新。

全球動脈瘤性蜘蛛網膜下腔出血市場趨勢

全球動脈瘤性蜘蛛網膜下腔出血市場正經歷著向微創技術顯著轉變的趨勢。醫療機構擴大採用先進的手術方案，例如血管內彈簧圈和血流導向裝置，這些方案能夠最大限度地減少創傷、縮短恢復時間並減少患者住院時間。這一趨勢促使醫院投資建造專業的導管室，並為醫護人員提供全面的培訓計畫。同時，保險公司也正在調整報銷政策以支持微創手術，從而為創新創造了更有利的環境。因此，製造商之間為爭奪市場佔有率而展開的競爭日益激烈，醫療設備技術和治療方法的調查方法也在加速推進。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太國家
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲國家

競爭資訊

前五大公司對比
主要公司2025年的市場定位
主要市場公司採取的策略
近期市場趨勢
企業市場占有率分析，2025 年
主要公司的完整公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 銷售收入年比比較（2023-2025 年）

主要公司簡介

Stryker Corporation
Medtronic
Johnson & Johnson
MicroPort Scientific Corporation
Terumo Corporation
Penumbra
Boston Scientific Corporation
Abbott Laboratories
Phenox
Kaneka Corporation
Asahi Intecc
Bayer AG
Pfizer
Novartis
Roche Holding
Sanofi
AstraZeneca
GlaxoSmithKline
Teva Pharmaceutical Industries
Edge Therapeutics

結論與建議

簡介目錄

Product Code: SQMIG35I3191

Global Aneurysmal Subarachnoid Hemorrhage Market size was valued at USD 170.0 Million in 2024 and is poised to grow from USD 173.4 Million in 2025 to USD 203.17 Million by 2033, growing at a CAGR of 2.0% during the forecast period (2026-2033).

The global aneurysmal subarachnoid hemorrhage (aSAH) market encompasses diagnostic tools, endovascular devices, neurosurgical instruments, and patient care services aimed at addressing intracranial aneurysm ruptures. Due to aSAH's high mortality rate and significant contribution to total strokes, there is a pressing need for advanced imaging and minimally invasive treatment options. The market has transitioned from surgical clipping to endovascular solutions, primarily driven by the adoption of coil embolization. This shift emphasizes rapid intervention, thus fostering investments in cutting-edge imaging technologies like CT and MRI, which not only enhance diagnosis but also expand patient access to treatment. The integration of AI-driven diagnostic imaging further accelerates this trend by improving detection accuracy and facilitating quicker clinical decision-making, ultimately broadening market opportunities, particularly in emerging regions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Aneurysmal Subarachnoid Hemorrhage market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Aneurysmal Subarachnoid Hemorrhage Market Segments Analysis

Global aneurysmal subarachnoid hemorrhage market is segmented by intervention type, end-user, distribution channel and region. Based on intervention type, the market is segmented into Surgical Clipping, Endovascular Coiling, Flow Diverters & Stents and Pharmacological Management. Based on end-user, the market is segmented into Hospitals & Neurological Centers and Ambulatory Surgical Centers. Based on distribution channel, the market is segmented into Direct and Indirect. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Aneurysmal Subarachnoid Hemorrhage Market

One of the key market drivers for the global aneurysmal subarachnoid hemorrhage market is the increasing prevalence of cerebral aneurysms and associated risk factors, such as hypertension, smoking, and genetic predispositions. As awareness surrounding neurological disorders grows, there is a rising demand for advanced diagnostic and therapeutic options. This situation is further exacerbated by the aging population, which typically has a higher incidence of cerebrovascular conditions. Innovations in minimally invasive surgical techniques and the development of specialized medical devices are also propelling market growth, as healthcare providers seek effective interventions to improve patient outcomes and reduce the burden of this critical health issue.

Restraints in the Global Aneurysmal Subarachnoid Hemorrhage Market

One significant market restraint for the global aneurysmal subarachnoid hemorrhage market is the high cost associated with advanced diagnostic imaging technologies and treatment options. These expenses can limit accessibility for patients and healthcare providers, particularly in low-resource settings. Additionally, the complexity of the condition often necessitates a multidisciplinary approach to care, which can further strain healthcare budgets. The lack of public awareness and understanding of aneurysmal subarachnoid hemorrhage also contributes to late diagnoses, hindering timely treatment and impacting overall market growth. Consequently, these factors may stifle investment and innovation within this critical area of healthcare.

Market Trends of the Global Aneurysmal Subarachnoid Hemorrhage Market

The Global Aneurysmal Subarachnoid Hemorrhage market is experiencing a significant shift towards the adoption of minimally invasive techniques. Healthcare providers are increasingly embracing advanced surgical options such as endovascular coils and flow diverters, which minimize trauma, enhance recovery times, and reduce hospital stays for patients. This trend is prompting hospitals to invest in specialized catheter laboratories and robust training programs for medical professionals. In tandem, insurance companies are adapting reimbursement policies to support less invasive procedures, creating a more favorable environment for innovation. As a result, there is heightened competition among manufacturers striving to capture market share, leading to accelerated advancements in device technology and treatment methodologies.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape

Global Aneurysmal Subarachnoid Hemorrhage Market Size by Intervention Type & CAGR (2026-2033)

Market Overview
Surgical Clipping
Endovascular Coiling
- Bare Platinum Coils
- Coated & Hydrogel Coils
Flow Diverters & Stents
Pharmacological Management

Global Aneurysmal Subarachnoid Hemorrhage Market Size by End-User & CAGR (2026-2033)

Market Overview
Hospitals & Neurological Centers
Ambulatory Surgical Centers

Global Aneurysmal Subarachnoid Hemorrhage Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Direct
Indirect

Global Aneurysmal Subarachnoid Hemorrhage Market Size & CAGR (2026-2033)

North America (Intervention Type, End-User, Distribution Channel)
- US
- Canada
Europe (Intervention Type, End-User, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Intervention Type, End-User, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Intervention Type, End-User, Distribution Channel)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Intervention Type, End-User, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Stryker Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Phenox
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kaneka Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Asahi Intecc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edge Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments